Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2017)
Bio-Rad Laboratories' (BIO) quarterly Change in Receivables came in at $20.6 million in Q3 2017, up 3629.67% year-over-year from $551737.2 in Q3 2016, and up 136.66% quarter-over-quarter from $8.7 million in Q2 2017.
Analysis
Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2017) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Change in Receivables for 9 consecutive years, with $20.6 million the latest figure, recorded in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | - |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | -71.00 Mn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | -22.00 Mn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 26.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 17.63 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 2.87 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 7.55 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 8.51 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 20.58 Mn |
| Jun 30, 2017 | 8.70 Mn |
| Mar 31, 2017 | -6.85 Mn |
| Sep 30, 2016 | -583,000.00 |
| Jun 30, 2016 | -12.08 Mn |
| Mar 31, 2016 | -19.99 Mn |
| Sep 30, 2015 | -7.14 Mn |
| Jun 30, 2015 | 5.71 Mn |
| Mar 31, 2015 | -15.57 Mn |
| Sep 30, 2014 | -5.08 Mn |
| Jun 30, 2014 | -6.50 Mn |
| Mar 31, 2014 | -39.57 Mn |
| Sep 30, 2013 | -21.28 Mn |
| Jun 30, 2013 | 20.93 Mn |
| Mar 31, 2013 | -14.45 Mn |
| Sep 30, 2012 | -4.95 Mn |
| Jun 30, 2012 | -2.35 Mn |
| Mar 31, 2012 | -17.58 Mn |
| Sep 30, 2011 | 1.03 Mn |
| Jun 30, 2011 | -1.76 Mn |